acne
acne
Explore linked clinical trials. Standard reference: MONDO:001143877 results · Page 1 of 4
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Determine Efficacy, Safety, and Tolerability of B244 as a Topical Spray in Subjects With Moderate to Severe Acne Vulgaris | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Not yet recruiting | Phase 2 | 2026-10-08 | NCT07866105 | |
| Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 3 | 2026-10-07 | NCT07863193 | |
| Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Not applicable | 2026-10-02 | NCT07058883 | |
| Facial Skin Microbiome in Patients With Moderate-to-Severe Acne Vulgaris Treated With Isotretinoin | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Not stated | 2026-10-01 | NCT07834138 | |
| Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06447480 | |
| Demodex Mites in Acne Patients and Herbal Extract Susceptibility | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, demodicidosis, sebaceous gland disorder, skin disorder | Not yet recruiting | Not stated | 2026-09-28 | NCT07845149 | |
| Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 3 | 2026-09-22 | NCT06905210 | |
| Safety of the Acne mRNA Vaccine in Adolescents 12 to 17 Years of Age With Moderate to Severe Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Not yet recruiting | Phase 2 | 2026-09-18 | NCT07756957 | |
| Prevalence of Polyendocrine Metabolic Ovarian Syndrome in Patients Diagnosed With Acne Vulgaris in Sohag University Hospital | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Not stated | 2026-09-16 | NCT07822360 | |
| A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT) | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Active, not recruiting | Phase 3 | 2026-09-15 | NCT07389109 | |
| AVAVA MIRIA General Use | Acneiform Eruptions, Fibrosis, Hypertrophy, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, severe cutaneous adverse reaction, skin disorder | Recruiting | Not applicable | 2026-09-15 | NCT06868615 | |
| The Impact of Baseline Hormonal Profiles (DHEAS, FSH, LH) on Treatment Response to Systemic Isotretinoin in Adult Female Patients With Acne Vulgaris | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Not stated | 2026-09-14 | NCT07818525 | |
| Radiofrequency Treatment Versus Topical Therapy for Facial Acne Vulgaris | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Not applicable | 2026-09-04 | NCT07805655 | |
| Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Active, not recruiting | Phase 4 | 2026-08-25 | NCT04582383 | |
| A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Active, not recruiting | Phase 3 | 2026-08-24 | NCT07186413 | |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-21 | NCT06316297 | |
| Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Not applicable | 2026-08-06 | NCT07749469 | |
| Clinical Observation of Skin Condition in Patients With Acne Vulgaris Using Ubiquinol, Pomegranate Peel Extract, Ceramide, and Salicylic Acid Emulsion | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Not yet recruiting | Not stated | 2026-07-29 | NCT07735169 | |
| Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 4 | 2026-07-29 | NCT07524946 | |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-09 | NCT07013747 | |
| A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology | Acneiform Eruptions, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, acne, atopic eczema, dermatitis, immune system disorder, psoriasis, sebaceous gland disorder, skin disorder, skin vascular disease, urticaria | Not yet recruiting | Not applicable | 2026-07-01 | NCT07481019 | |
| A Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy Adults | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Not yet recruiting | Not applicable | 2026-06-30 | NCT07127523 | |
| Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense | Acneiform Eruptions, Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, acne, bacterial infectious disease, dermatitis, hidradenitis, hidradenitis suppurativa, sebaceous gland disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Active, not recruiting | Phase 2 | 2026-06-30 | NCT06993610 | |
| Comparison of Topical Clascoterone and Adapalene for Mild Acne Vulgaris | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Not yet recruiting | Early phase 1 | 2026-06-29 | NCT07673094 | |
| The Suitability of Tience® for Treating Acne Scars | Acneiform Eruptions, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Skin and Connective Tissue Diseases, acne, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, sebaceous gland disorder, skin disorder | Active, not recruiting | Not applicable | 2026-06-23 | NCT07368764 |